Won, Ki-Bum
Lee, Byoung Kwon
Lin, Fay Y.
Hadamitzky, Martin
Kim, Yong-Jin
Sung, Ji Min
Conte, Edoardo
Andreini, Daniele
Pontone, Gianluca
Budoff, Matthew J.
Gottlieb, Ilan
Chun, Eun Ju
Cademartiri, Filippo
Maffei, Erica
Marques, Hugo
de Araújo Gonçalves, Pedro
Leipsic, Jonathon A.
Lee, Sang-Eun
Shin, Sanghoon
Choi, Jung Hyun
Virmani, Renu
Samady, Habib
Chinnaiyan, Kavitha
Berman, Daniel S.
Narula, Jagat
Shaw, Leslee J.
Bax, Jeroen J.
Min, James K.
Chang, Hyuk-Jae
Funding for this research was provided by:
Ministry of Science and ICT, South Korea (202016B02)
Article History
Received: 18 July 2022
Accepted: 26 September 2022
First Online: 12 November 2022
Declarations
:
: The study protocol was approved by the ethics committee of each participating institution. Informed consent for the procedure was obtained from each participant.
: Not applicable.
: Dr. Jonathon A. Leipsic serves as a consultant and has stock options in HeartFlow and Circle Cardiovascular Imaging; he also receives grant support from GE Healthcare and speaking fees from Philips. Dr. Habib Samady has an equity interest in Covanos. Dr. Daniel Berman receives software royalties from Cedars-Sinai Medical Center. Dr. James K. Min receives funding from the Dalio Foundation, National Institutes of Health, and GE Healthcare. Dr. Min serves on the scientific advisory board of Arineta and GE Healthcare and has an equity interest in Cleerly. All other authors declare that they have no competing interests.